Michael del Aguila, PhD
Chief Commercial Officer
Dr. Michael del Aguila comes with years of experience holding executive positions at Roche, Genentech, Bristol Myers Squibb, and Gilead. He has led teams responsible for pricing and market access, sponsored real-world evidence research, as well as conducting clinical and observational studies in Health Economics and Outcomes Research. Michael’s executive leadership in consulting services has also focused on these essential domains. Michael is excited to lead Evidinno’s continued growth trajectory and holds a PhD in Epidemiology from the University of Washington.
Interests/hobbies: Theater, live music, hiking, and running